 |
市场调查报告书
商品编码
1767696
消化性溃疡药物市场按产品类型、适应症、通路和地区划分Peptic Ulcer Drugs Market, By Product Type, by Disease Indication, By Distribution Channel, By Geography |
||||||
价格
简介目录
消化性溃疡药物市场规模预计在 2025 年为 372.2 亿美元，预计到 2032 年将达到 493.1 亿美元，2025 年至 2032 年的复合年增长率为 4.1%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 372.2亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年 | 4.10% | 2032年价值预测 | 493.1亿美元 |
消化性溃疡是胃壁和小肠上段的开放性溃疡。消化性溃疡最常见的症状是胃痛。消化性溃疡有两种：胃溃疡（发生于胃壁）和十二指肠溃疡（发生于小肠上段）。消化性溃疡最常见的原因是感染幽门螺旋桿菌 (H. pylori) 和长期服用非类固醇消炎剂(NSAID)，例如Ibuprofen（Advil、 Motrin IB 等）和萘普生钠（Aleve）。压力和辛辣食物不会导致消化性溃疡，但它们可能会加重症状。
消化性溃疡最常见的症状是胃部灼热。胃酸和空腹都会加剧疼痛。当胃或小肠上段出现溃疡时，就会引发消化性溃疡。大多数消化性溃疡是由细菌感染引起的，这些细菌会侵蚀消化器官系统的保护层。经常服用止痛药的人更容易患上溃疡。
市场动态
预计在预测期内，监管产品认证的增加将推动市场成长。例如，2021年12月，製药公司Edenbridge Pharmaceuticals宣布，美国食品药物管理局已核准Glico口溶锭用于减轻消化性溃疡症状，并作为消化性溃疡的辅助治疗。
研究的主要特点
- 本报告对全球消化性溃疡治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球消化性溃疡药物市场的主要企业概况。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球消化性溃疡药物市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员将透过全球消化性溃疡药物市场分析中使用的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- 一致的机会图（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 市场机会
- 影响分析
- 最新产品发布
- 流行病学
- 合併、收购与合作
- 监管情景
- PEST分析
- 管道分析
4. 全球消化性溃疡药物市场（依产品类型），2020 年至 2032 年
- 介绍
- 质子帮浦抑制剂
- 钾竞争性抗酸药（P-CAB）
- 制酸剂
- H2拮抗剂
- 抗生素
- 溃疡保护
5. 2020-2032 年全球消化性溃疡药物市场（依适应症划分）
- 介绍
- 胃炎
- 胃溃疡
- 十二指肠溃疡
- 胃食道逆流症（GERD）
6. 2020-2032 年全球消化性溃疡药物市场（依通路）
- 介绍
- 医院药房
- 零售药局
- 网路药局
7. 2020-2032 年全球消化性溃疡药物市场（按地区）
- 介绍
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第八章 竞争态势
- Daewoong Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Pfizer Inc.
- AstraZeneca plc.
- RedHill Biopharma
- Cadila Healthcare Ltd.
- Novitium Pharma LLC.
- Boehringer Ingelheim GmbH
- Eisai Co. Ltd.
- Yuhan Corporation
- GlaxoSmithKline plc.
第九章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI3246
Peptic Ulcer Drugs Market is estimated to be valued at USD 37.22 Bn in 2025 and is expected to reach USD 49.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 37.22 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.10% | 2032 Value Projection: | USD 49.31 Bn |
Peptic ulcers are open sores that develop on the inside lining of your stomach and the upper portion of your small intestine. The most common symptom of a peptic ulcer is stomach pain. Peptic ulcers include: Gastric ulcers that occur on the inside of the stomach and Duodenal ulcers that occur on the inside of the upper portion of your small intestine (duodenum). The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve). Stress and spicy foods do not cause peptic ulcers. However, they can make your symptoms worse.
The most common peptic ulcer symptom is burning stomach pain. Stomach acid makes the pain worse, as does having an empty stomach. Peptic ulcer disease occurs when open sores, or ulcers, form in the stomach or first part of the small intestine. Many cases of peptic ulcer disease develop because a bacterial infection eats away the protective lining of the digestive system. People who frequently take pain relievers are more likely to develop ulcers.
Market Dynamics
An increase in product approval from the regulatory bodies is expected to drive the growth of the market over the forecast period. For instance, in December 2021, Edenbridge Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration have approved glycopyrrolate orally disintegrating tablets to reduce the symptoms of a peptic ulcer and as an adjunct to treatment of peptic ulcers.
Key features of the study
- This report provides an in-depth analysis of the global peptic ulcer drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global peptic ulcer drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Daewoong Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd., Pfizer Inc., AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, GlaxoSmithKline plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global peptic ulcer drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptic ulcer drugs market
Market Segmentation
- Global Peptic Ulcer Drugs Market, By Product Type
- Proton Pump Inhibitors
- Potassium-Competitive Acid Blocker (P-CAB)
- Antacids
- H2- Antagonist
- Antibiotics
- Ulcer Protective
- Global Peptic Ulcer Drugs Market, By Disease Indication
- Gastitis
- Gastric Ulcer
- Duodenal Ulcer
- Gastroesophageal Reflux Disease (GERD)
- Global Peptic Ulcer Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Peptic Ulcer Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Daewoong Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Co., Ltd.
- Pfizer Inc.
- AstraZeneca plc.
- RedHill Biopharma
- Cadila Healthcare Ltd.
- Novitium Pharma LLC.
- Boehringer Ingelheim GmbH
- Eisai Co. Ltd.
- Yuhan Corporation
- GlaxoSmithKline plc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Pipeline Analysis
4. Global Peptic Ulcer Drugs Market, By Product Type, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Potassium-Competitive Acid Blocker (P-CAB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- H2- Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Ulcer Protective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
5. Global Peptic Ulcer Drugs Market, By Disease Indication, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Gastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Gastric Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Duodenal Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Global Peptic Ulcer Drugs Market, By Region, 2020 - 2032, (US$ Billion)
- Overview
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Daewoong Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RedHill Biopharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cadila Healthcare Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novitium Pharma LLC.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eisai Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Yuhan Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
9. Section
- Research Methodology
- About Us
